The majority of the patients were lacking the golden drug in management: beta-blockers in mitral stenosis, ACE inhibitors or ARBs in mitral and aortic regurgitation, and digoxin, antiplatelets, and statins in aortic stenosis. This evidence concerns the gene ACE and aortic valve insufficiency.